A-1 Solution
NDC Package 58264-0293-1
Package Information
A-1 (capra hircus skin, felis catus skin, bos taurus skin, canis lupus familiaris skin, equus caballus skin, capra hircus hair, and sheep wool) solution is a medication used as Allergies. This formulation utilizes a solution delivery system. Marketed by Dna Labs, Inc., this product is identified by NDC 58264-0293.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Allergens - [CS]
- Animal Fur - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Cells, Epidermal - [EXT]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Animal Hair Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Animal Skin Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Standardized Animal Skin Allergenic Extract - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 58264 - Dna Labs, Inc.
- 58264-0293 - A-1
- 58264-0293-1 - 29.57 mL in 1 BOTTLE, GLASS
- 58264-0293 - A-1
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58264-0293-1 identifies a specific commercial package of 29.57 ml in 1 bottle, glass of A-1, a human over the counter drug labeled by Dna Labs, Inc.. This solution is formulated for sublingual use and contains bos taurus skin; canis lupus familiaris skin; capra hircus hair; capra hircus skin; equus caballus skin; felis catus skin; sheep wool as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dna Labs, Inc. on January 01, 1990. The current certification is valid through December 31, 2026.
How is this Dna Labs, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58264029301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.